Portico Ventures spinout uses AI and space tech to fight cancer

UCL spinout Odin Vision has secured £1.2 mil to develop a bowel cancer detection solution that uses machine learning and satellite communications to improve diagnosis efficiency. The company have been supported through UCLB‘s Portico Ventures programme and received financial backing from the UCL Technology Fund, AI Seed, the London Co-Investment Fund, Innovate UK, the UK Space Agency and the European Space Agency.

Bowel cancer is the second most common cause of cancer-related deaths in the UK and detecting it using traditional colonoscopy methods can be challenging for doctors. With a survival rate of 90% through early diagnosis, new ways of identifying and diagnosing cancerous growths sooner are vital.

The team of UCL engineers and clinicians behind the company are developing a revolutionary AI system that identifies and characterises polyps by analysing live colonoscopy video, leading to early treatment and saved lives. It uses the same technology for reliably delivering data quickly between Earth and spacecraft up to millions of miles away.

Their project will use secure, high-speed satellite communications with bespoke space compression software to create a cloud-based AI system that can support doctors in their decision making. Through the use of space technology, the system can be deployed anywhere on earth enabling patients to receive a consistent, high level of care.

Find out more about Odin Vision’s technology, vision, commercialisation plans and funding, or have a look at their interview on the BBC.